BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36101669)

  • 1. Erratum: miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer [Corrigendum].
    Cancer Manag Res; 2022; 14():2671-2672. PubMed ID: 36101669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer.
    Zhan T; Zhu Q; Han Z; Tan J; Liu M; Liu W; Chen W; Chen X; Chen X; Deng J; Tian X; Huang X
    Cancer Manag Res; 2020; 12():1483-1492. PubMed ID: 32161500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L.
    Zhan T; Chen X; Tian X; Han Z; Liu M; Zou Y; Huang S; Chen A; Cheng X; Deng J; Tan J; Huang X
    Technol Cancer Res Treat; 2020; 19():1533033820945801. PubMed ID: 32924881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling.
    Liang J; Liu Y; Zhang L; Tan J; Li E; Li F
    Chem Biol Interact; 2019 May; 304():1-9. PubMed ID: 30831090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Upregulation of Family with Sequence Similarity 83 Member D Expression Enhances Cell Proliferation and Motility via Activation of Wnt/β-Catenin Signaling and Predicts Poor Prognosis in Gastric Cancer [Corrigendum].
    Cancer Manag Res; 2021; 13():3381-3383. PubMed ID: 33889026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
    Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
    Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
    Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
    Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
    [No Abstract]   [Full Text] [Related]  

  • 10. miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.
    Higashi T; Hayashi H; Ishimoto T; Takeyama H; Kaida T; Arima K; Taki K; Sakamoto K; Kuroki H; Okabe H; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
    Br J Cancer; 2015 Jul; 113(2):252-8. PubMed ID: 26125451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI.
    Chen N; Yang H; Song L; Li H; Liu Y; Wu D
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33274736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Long Noncoding RNA GAS5 Acts As A Tumor Suppressor In Laryngeal Squamous Cell Carcinoma Via miR-21 [Corrigendum].
    Cancer Manag Res; 2019; 11():9047. PubMed ID: 31695496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum].
    Cancer Manag Res; 2021; 13():2907. PubMed ID: 33833573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of microRNA-200c-3p inhibits invasion and migration of renal cell carcinoma cells via the SOX2-dependent Wnt/β-catenin signaling pathway.
    Li S; Feng Z; Zhang X; Lan D; Wu Y
    Cancer Cell Int; 2019; 19():231. PubMed ID: 31516388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-543-3p promotes growth and stem cell-like phenotype in bladder cancer by activating the Wnt/β-catenin signaling pathway.
    Gao RL; Chen XR; Li YN; Yan XY; Sun JG; He QL; Cai FZ
    Int J Clin Exp Pathol; 2017; 10(9):9418-9426. PubMed ID: 31966814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
    Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
    Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
    Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
    Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.